I 

118TH CONGRESS 

2D SESSION H. R. 7551 

To prohibit any Federal law from making the manufacturer of a COVID– 

19 vaccine immune from suit or liability, or limiting the liability of 

such a manufacturer, with respect to claims for loss caused by, arising 

out of, relating to, or resulting from the administration to or the use 

by an individual of a COVID–19 vaccine, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 5, 2024 

Mr. ROY (for himself, Mr. WEBER of Texas, Ms. BOEBERT, Mr. HIGGINS of 

Louisiana, Mrs. MILLER of Illinois, Mr. BRECHEEN, Mr. CLOUD, Mr. 

MASSIE, Mr. GOOD of Virginia, Mr. DAVIDSON, Mr. BURLISON, Mr. NORMAN, Mr. NEHLS, Mr. MOORE of Alabama, Mr. HARRIS, Mr. GOSAR, Mr. 

CRANE, Mr. FULCHER, Mr. BIGGS, and Mr. DESJARLAIS) introduced the 

following bill; which was referred to the Committee on the Judiciary 

A BILL 

To prohibit any Federal law from making the manufacturer 

of a COVID–19 vaccine immune from suit or liability, 

or limiting the liability of such a manufacturer, with 

respect to claims for loss caused by, arising out of, 

relating to, or resulting from the administration to or 

the use by an individual of a COVID–19 vaccine, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7551 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Let Injured Americans 

3 Be Legally Empowered Act’’ or the ‘‘LIABLE Act’’. 

4 SEC. 2. NO FEDERAL IMMUNITY FROM, OR LIMITATION ON, 

5 LIABILITY FOR MANUFACTURERS FOR LOSS 

6 CAUSED BY A COVID–19 VACCINE. 

7 (a) IN GENERAL.—No Federal law, including sec8 tions 319F–3, 2111, and 2122 of the Public Health Serv9 ice Act (42 U.S.C. 247d–6d, 300aa–11, 300aa–22), may 

10 make the manufacturer of a COVID–19 vaccine immune 

11 from suit or liability, or limit the liability of such a manu12 facturer, with respect to claims for loss caused by, arising 

13 out of, relating to, or resulting from the administration 

14 to or the use by an individual of a COVID–19 vaccine. 

15 (b) RULE OF CONSTRUCTION.—Nothing in this Act 

16 shall be construed to prohibit an individual from seeking 

17 compensation through the Countermeasures Injury Com18 pensation Program under section 319F–4 of the Public 

19 Health Service Act (42 U.S.C. 247d–6e) or the National 

20 Vaccine Injury Compensation Program under subtitle 2 

21 of title XXI of such Act (42 U.S.C. 300aa–10 et seq.). 

22 (c) RELATION TO OTHER PROGRAMS.—An individual 

23 shall not be precluded from bringing a civil action for 

24 claims described in subsection (a) on the basis of such in25 dividual having sought or received compensation through 

26 the Countermeasures Injury Compensation Program 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7551 IH

1 under section 319F–4 of the Public Health Service Act 

2 (42 U.S.C. 247d–6e) or the National Vaccine Injury Com3 pensation Program under subtitle 2 of title XXI of such 

4 Act (42 U.S.C. 300aa–10 et seq.). 

5 (d) DEFINITION.—The term ‘‘COVID–19 vaccine’’ 

6 means a vaccine licensed or otherwise authorized by the 

7 Food and Drug Administration to prevent, mitigate, or 

8 limit— 

9 (1) the harm from COVID–19; or 

10 (2) the transmission of SARS–CoV–2 or a virus 

11 mutating therefrom. 

12 (e) RETROACTIVE APPLICABILITY.—This Act applies 

13 without regard to whether the adminstration or use of a 

14 COVID–19 vaccine occurs before, on, or after the date of 

15 enactment of this Act. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB